ING4 dysregulation correlates with pathophysiological process of many tumors, such as astrocytomas [153], clear-cell renal carcinoma [154], glioblastoma [97], glioma [155] and hepatocellular carcinoma [156]. The gene discussed is ING4; the disease is central nervous system cancer.